HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
View/ Open
Volume
79
Pagination
129 - 138
DOI
10.1016/j.ejca.2017.03.033
Journal
EUROPEAN JOURNAL OF CANCER
ISSN
0959-8049
Metadata
Show full item recordAuthors
Bartlett, JMS; Ahmed, I; Regan, MM; Sestak, I; Mallon, EA; Dell'Orto, P; Thurlimann, B; Seynaeve, C; Putter, H; Van de Velde, CJHCollections
- Centre for Cancer Prevention [1096]